196 related articles for article (PubMed ID: 10924389)
1. Marek's disease: an update on oncogenic mechanisms and control.
Venugopal K
Res Vet Sci; 2000 Aug; 69(1):17-23. PubMed ID: 10924389
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence.
Shamblin CE; Greene N; Arumugaswami V; Dienglewicz RL; Parcells MS
Vet Microbiol; 2004 Sep; 102(3-4):147-67. PubMed ID: 15327791
[TBL] [Abstract][Full Text] [Related]
3. Evolution of Marek's disease -- a paradigm for incessant race between the pathogen and the host.
Nair V
Vet J; 2005 Sep; 170(2):175-83. PubMed ID: 16129338
[TBL] [Abstract][Full Text] [Related]
4. Vaccinal control of Marek's disease: current challenges, and future strategies to maximize protection.
Baigent SJ; Smith LP; Nair VK; Currie RJ
Vet Immunol Immunopathol; 2006 Jul; 112(1-2):78-86. PubMed ID: 16682084
[TBL] [Abstract][Full Text] [Related]
5. In vitro characterization of the Meq proteins of Marek's disease virus vaccine strain CVI988.
Ajithdoss DK; Reddy SM; Suchodolski PF; Lee LF; Kung HJ; Lupiani B
Virus Res; 2009 Jun; 142(1-2):57-67. PubMed ID: 19189855
[TBL] [Abstract][Full Text] [Related]
6. Marek's disease: the continuing struggle between pathogen and host.
Witter RL
Vet J; 2005 Sep; 170(2):149-50. PubMed ID: 16129335
[No Abstract] [Full Text] [Related]
7. Biocharacteristics shared by highly protective vaccines against Marek's disease.
Gimeno IM; Witter RL; Hunt HD; Reddy SM; Reed WM
Avian Pathol; 2004 Feb; 33(1):59-68. PubMed ID: 14681069
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of oncogenic genes revealed unique evolutionary features of field Marek's disease virus prevalent in recent years in China.
Tian M; Zhao Y; Lin Y; Zou N; Liu C; Liu P; Cao S; Wen X; Huang Y
Virol J; 2011 Mar; 8():121. PubMed ID: 21406076
[TBL] [Abstract][Full Text] [Related]
9. Marek's disease and new approaches to its control.
Zelník V
Acta Virol; 1995 Feb; 39(1):53-63. PubMed ID: 7572471
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy of BAC-derived recombinant SB-1 vaccine and the parent wild type strain in preventing replication, shedding and disease induced by virulent Marek's disease virus.
Singh SM; Baigent SJ; Petherbridge LJ; Smith LP; Nair VK
Res Vet Sci; 2010 Aug; 89(1):140-5. PubMed ID: 20144837
[TBL] [Abstract][Full Text] [Related]
11. Marek's disease: a model for protection against herpesvirus-induced tumours.
Schat KA
Cancer Surv; 1987; 6(1):1-37. PubMed ID: 2825984
[TBL] [Abstract][Full Text] [Related]
12. Marek's disease virus: lytic replication, oncogenesis and control.
Jarosinski KW; Tischer BK; Trapp S; Osterrieder N
Expert Rev Vaccines; 2006 Dec; 5(6):761-72. PubMed ID: 17184215
[TBL] [Abstract][Full Text] [Related]
13. Successful control of Marek's disease by vaccination.
Nair V
Dev Biol (Basel); 2004; 119():147-54. PubMed ID: 15742626
[TBL] [Abstract][Full Text] [Related]
14. Sequence analysis of meq oncogene among Polish strains of Marek's disease.
Woźniakowski G; Samorek-Salamonowicz E; Kozdruń W
Pol J Vet Sci; 2010; 13(2):263-7. PubMed ID: 20731180
[TBL] [Abstract][Full Text] [Related]
15. Use of Marek's disease vaccines: could they be driving the virus to increasing virulence?
Davison F; Nair V
Expert Rev Vaccines; 2005 Feb; 4(1):77-88. PubMed ID: 15757475
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization and phylogenetic analysis of oncogenes from virulent serotype-1 Marek's disease virus in India.
Prathibha Y; Sreedevi B; Kumar NV; Srilatha CH
Acta Virol; 2018; 62(3):277-286. PubMed ID: 30160143
[TBL] [Abstract][Full Text] [Related]
17. Newly detected mutations in the Meq oncogene and molecular pathotyping of very virulent Marek's disease herpesvirus in Tunisia.
Lachheb J; Mastour H; Nsiri J; Kaboudi K; Choura I; Ammouna F; Amara A; Ghram A
Arch Virol; 2020 Nov; 165(11):2589-2597. PubMed ID: 32876794
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation the immuno-protective effect of an infectious clone of meq- deleted Marek's disease virus].
Li Y; Kang M; Su S; Ding J; Cui Z; Zhu H
Wei Sheng Wu Xue Bao; 2010 Jul; 50(7):942-8. PubMed ID: 20815243
[TBL] [Abstract][Full Text] [Related]
19. Influence of B-haplotype on the relative efficacy of Marek's disease vaccines of different serotypes.
Bacon LD; Witter RL
Avian Dis; 1993; 37(1):53-9. PubMed ID: 8383961
[TBL] [Abstract][Full Text] [Related]
20. Pathotyping of Australian isolates of Marek's disease virus and association of pathogenicity with meq gene polymorphism.
Renz KG; Cooke J; Clarke N; Cheetham BF; Hussain Z; Fakhrul Islam AF; Tannock GA; Walkden-Brown SW
Avian Pathol; 2012; 41(2):161-76. PubMed ID: 22515535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
